GlassScriptPhysician profile
Guy P Zeringue
NPI 1255430211
$2,627.10
in general payments reported to CMS, 2019-2025
22 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $514 · 2021: $292 · 2022: $313 · 2023: $475 · 2024: $125 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $664.93 | 2019-2024 | |
| Acclarent, INC | $635.23 | 2019-2023 | Trudi Nav Cable, Acclarent Navwire, Spine & Trauma 3d Navigation |
| Genzyme Corporation | $244.15 | 2019-2025 | |
| Glaxosmithkline, LLC. | $236.74 | 2022-2025 | Nucala |
| Optinose US, INC. | $236.19 | 2019-2025 | |
| Stryker Corporation | $125.82 | 2019-2023 | Audion Et Dilation System |
| Inspire Medical Systems, INC. | $122.13 | 2025 | Inspire |
| Jazz Pharmaceuticals INC. | $66.93 | 2020 | |
| Abbvie INC. | $39.16 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $35.37 | 2021-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $33.63 | 2019-2024 | |
| Davol INC. | $25.01 | 2023 | Arista Ah Flexitip |
| Paratek Pharmaceuticals, INC. | $23.97 | 2025 | Nuzyra, Xhance |
| Intersect Ent, INC. | $19.70 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.82 | 2023 | Exparel, Iovera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $16.50 | 2024 | Ryaltris |
| Kaleo, INC. | $16.03 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.23 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.09 | 2019 | |
| Tactile Systems Technology INC | $14.24 | 2021 | |
| Cook Medical LLC | $12.61 | 2020 | |
| Merck Sharp & Dohme LLC | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Zeringue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.